CELLDEX THERAPEUTICS INC (CLDX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CLDX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CLDX | Director | 72 | ["Chief Executive Officer at Avalo Therapeutics since February 2022","Chairman of the Board at Avalo Therapeutics from August 2022 to March 2025","Senior Scientific Adviser and Chief Scientific Officer from February 2020 to February 2022","Former Chief Scientific Officer at Avalo Therapeutics from September 2013 to February 2020","Corporate Vice President of Science & Technology at Johnson & Johnson from November 2007 to August 2012","Former Group President at Johnson & Johnson Pharmaceutical Research and Development","Former Vice President of Research & Development at Merck KGaA/EMD Pharmaceuticals","Former Vice President of Clinical Research at AstraZeneca and Astra Merck","Board of directors at Arena Pharmaceuticals, Inc. since February 2017","Chair at Arena Pharmaceuticals, Inc. since February 2021","Former board member at Zura Bio Limited from March 2023 to November 2023","Former board member at GTx, Inc. from August 2016 to May 2019","Board of the Center for Discovery and Innovation at Hackensack Meridian Medical School","Founding Chairman and past member of the board at TransCelerate Biopharma, Inc. from 2012 to 2019","Former board member at Reagan Udall Foundation for the FDA from 2007 to 2021","Former board member at National Institutes of Health from 2010 to 2012","Former Chairman of Science and Regulatory Executive Committee and the PhRMA Foundation Board"] | ["Audit","Nominating and Corporate Governance"] | 2026 |
Biography sourced from the proxy statement filing.
GARRY NEIL, M.D., 72
CARIEER HIGHLIGHTS
Director since June 2022
Avalo Therapeutics*
Chief Executive Officer since February 2022 and Chairman of the Board from August 2022 to March 2025
Senior Scientific Adviser and Chief Scientific Officer from February 2020 to February 2022
Served as Chief Scientific Officer from September 2013 to February 2020
PUBLIC BOARDS: 2
Apple Tree Partners
Partner from September 2012 to September 2013
COMMITTEES: Audit, Nominating and Corporate Governance
Johnson & Johnson
Corporate Vice President of Science & Technology from November 2007 to August 2012
Pharmaceutical Research and Development
Former Group President
EDUCATION: B.S. from the University of Saskatchewan and an M.D. from the University of Saskatchewan College of Medicine. He completed postdoctoral clinical training in internal medicine and gastroenterology at the University of Toronto. Dr. Neil also completed a postdoctoral research fellowship at the Research Institute of Scripps Clinic
Merck KGaA/EMD Pharmaceuticals
Former Vice President of Research & Development
AstraZeneca and Astra Merck
Former Vice President of Clinical Research
Arena Pharmaceuticals, Inc.
Board of directors since February 2017 and as its Chair since February 2021
Zura Bio Limited*
Board of directors from March 2023 to November 2023
GTx, Inc.
Board of directors from August 2016 to May 2019
Hackensack Meridian Medical School in Hackensack, New Jersey
Board of the Center for Discovery and Innovation
TransCelerate Biopharma, Inc.
Founding Chairman and past member of the board from 2012 to 2019
Reagan Udall Foundation for the FDA
Board of directors from 2007 to 2021
National Institutes of Health
Board of Foundation from 2010 to 2012 and the Science Management Review Board from 2010 to 2012
Pharmaceutical Research and Manufacturers Association (PhRMA)
Former Chairman of Science and Regulatory Executive Committee and the PhRMA Foundation Board